These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14572163)

  • 1. A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms.
    Nakagami H; Jensen KS; Liao JK
    Ann Med; 2003; 35(6):398-403. PubMed ID: 14572163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and myocardial hypertrophy.
    Nakagami H; Liao JK
    Coron Artery Dis; 2004 Aug; 15(5):247-50. PubMed ID: 15238820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the myocardium.
    Mital S; Liao JK
    Semin Vasc Med; 2004 Nov; 4(4):377-84. PubMed ID: 15861318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
    Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
    Takemoto M; Node K; Nakagami H; Liao Y; Grimm M; Takemoto Y; Kitakaze M; Liao JK
    J Clin Invest; 2001 Nov; 108(10):1429-37. PubMed ID: 11714734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy for cardiac hypertrophy and heart failure.
    Liao JK
    J Investig Med; 2004 May; 52(4):248-53. PubMed ID: 15521546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
    Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
    Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Tanaka S; Fukumoto Y; Nochioka K; Minami T; Kudo S; Shiba N; Takai Y; Williams CL; Liao JK; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1591-600. PubMed ID: 23640485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Custodis F; Eberl M; Kilter H; Böhm M; Laufs U
    Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease.
    Adam O; Laufs U
    Antioxid Redox Signal; 2014 Mar; 20(8):1238-50. PubMed ID: 23919665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential endothelial hydrogen peroxide signaling via Nox isoforms: Critical roles for Rac1 and modulation by statins.
    Waldeck-Weiermair M; Yadav S; Kaynert J; Thulabandu VR; Pandey AK; Spyropoulos F; Covington T; Das AA; Krüger C; Michel T
    Redox Biol; 2022 Dec; 58():102539. PubMed ID: 36401888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase.
    Kwok JM; Ma CC; Ma S
    Vascul Pharmacol; 2013 Jan; 58(1-2):21-30. PubMed ID: 23085091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis: Novel Mechanism of the Pleiotropic Effects of Statins.
    Kudo S; Satoh K; Nogi M; Suzuki K; Sunamura S; Omura J; Kikuchi N; Kurosawa R; Satoh T; Minami T; Ikeda S; Miyata S; Shimokawa H
    Hypertension; 2016 May; 67(5):878-89. PubMed ID: 26975711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
    Maack C; Kartes T; Kilter H; Schäfers HJ; Nickenig G; Böhm M; Laufs U
    Circulation; 2003 Sep; 108(13):1567-74. PubMed ID: 12963641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits.
    Brown JH; Del Re DP; Sussman MA
    Circ Res; 2006 Mar; 98(6):730-42. PubMed ID: 16574914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits protein isoprenylation in the brain.
    Ostrowski SM; Johnson K; Siefert M; Shank S; Sironi L; Wolozin B; Landreth GE; Ziady AG
    Neuroscience; 2016 Aug; 329():264-74. PubMed ID: 27180285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin activates the PPARγ-dependent pathway to prevent left ventricular hypertrophy associated with inhibition of RhoA signaling.
    Zou C; Qi H; Liu ZH; Han L; Zhao C; Yang X
    Tex Heart Inst J; 2013; 40(2):140-7. PubMed ID: 23678211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase.
    Park HJ; Galper JB
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11525-30. PubMed ID: 10500210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.